AD.BIOTECH.CORP. DL-,0001AD.BIOTECH.CORP. DL-,0001AD.BIOTECH.CORP. DL-,0001

AD.BIOTECH.CORP. DL-,0001

No trades
See on Supercharts
Market capitalization
‪349.73 M‬EUR
−1.413EUR
‪−204.08 M‬EUR
‪154.27 M‬EUR
‪138.51 M‬
Beta (1Y)
3.09

About AD.BIOTECH.CORP. DL-,0001

CEO
Chad Robins
Headquarters
Seattle
Employees (FY)
709
Founded
2009
FIGI
BBG00S6S78D1
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange AD.BIOTECH.CORP. DL-,0001 stocks are traded under the ticker 1HM.
AD.BIOTECH.CORP. DL-,0001 is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
1HM earnings for the last quarter are −0.33 EUR per share, whereas the estimation was −0.32 EUR resulting in a −3.35% surprise. The estimated earnings for the next quarter are −0.30 EUR per share. See more details about AD.BIOTECH.CORP. DL-,0001 earnings.
AD.BIOTECH.CORP. DL-,0001 revenue for the last quarter amounts to ‪35.87 M‬ EUR despite the estimated figure of ‪40.64 M‬ EUR. In the next quarter revenue is expected to reach ‪43.90 M‬ EUR.
Yes, you can track AD.BIOTECH.CORP. DL-,0001 financials in yearly and quarterly reports right on TradingView.
1HM net income for the last quarter is ‪−62.91 M‬ EUR, while the quarter before that showed ‪−47.58 M‬ EUR of net income which accounts for −32.22% change. Track more AD.BIOTECH.CORP. DL-,0001 financial stats to get the full picture.
No, 1HM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 1HM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AD.BIOTECH.CORP. DL-,0001 stock right from TradingView charts — choose your broker and connect to your account.
1HM reached its all-time high on Jan 19, 2021 with the price of 59.500 EUR, and its all-time low was 0.001 EUR and was reached on Mar 26, 2015.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has 709.00 employees. See our rating of the largest employees — is AD.BIOTECH.CORP. DL-,0001 on this list?
We've gathered analysts' opinions on AD.BIOTECH.CORP. DL-,0001 future price: according to them, 1HM price has a max estimate of 9.23 EUR and a min estimate of 4.62 EUR. Read a more detailed AD.BIOTECH.CORP. DL-,0001 forecast: see what analysts think of AD.BIOTECH.CORP. DL-,0001 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AD.BIOTECH.CORP. DL-,0001 EBITDA is ‪−157.54 M‬ EUR, and current EBITDA margin is −105.34%. See more stats in AD.BIOTECH.CORP. DL-,0001 financial statements.